New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance

Annual Review of Medicine

Volumn 69, Issue , 2018, Pages 379-394

  Tsalik, Ephraim L ^a,b   Bonomo, Robert A ^c,d   Fowler, Vance G ^a,e  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Gene expression profiling; Host response diagnostics; Host pathogen interactions; Infectious diseases diagnostics; Nucleic acid biomarkers; Point of care testing

Indexed keywords

ANTIBIOTIC AGENT; NUCLEIC ACID; BIOLOGICAL MARKER;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLINICAL DECISION MAKING; ELECTROSPRAY MASS SPECTROMETRY; GENE IDENTIFICATION; HUMAN; IMMUNE RESPONSE; MASS SPECTROMETRY; METABOLOMICS; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOMICS; PYROSEQUENCING; RESPIRATORY TRACT DISEASE; TUBERCULOSIS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PROCEDURES;

BACTERIAL INFECTIONS; BIOMARKERS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE TESTING;

EID: 85041707966     PISSN: 00664219     EISSN: 1545326X     Source Type: Book Series    
DOI: 10.1146/annurev-med-052716-030320     Document Type: Article

References (57)

1. Woods CW, McClain MT, Chen M, et al. 2013. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLOS ONE 8:e52198
2. Daniels JM, SchoorlM, Snijders D, et al. 2010. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138:1108-15
3. Tsalik EL, Jaggers LB, Glickman SW, et al. 2012. Discriminative value of inflammatory biomarkers for suspected sepsis. J. Emerg. Med. 43:97-106
4. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. 2013. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect. Dis. 13:426-35
5. West M. 2003. Bayesian factor regression models in the "large p, small n" paradigm. Bayesian Stat. 7:723-32
6. Aittokallio T, Kurki M, Nevalainen O, et al. 2003. Computational strategies for analyzing data in gene expression microarray experiments. J. Bioinform. Comput. Biol. 1:541-86
7. Dunkler D, Sanchez-Cabo F, Heinze G. 2011. Statistical analysis principles for omics data. Methods Mol. Biol. 719:113-31
8. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, et al. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447:799-816
9. Clarke LE, Warf MB, Flake DD 2nd, et al. 2015. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J. Cutan. Pathol. 42:244-52
10. Deng MC, Eisen HJ,Mehra MR, et al. 2006. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am. J. Transplant. 6:150-60
11. Crespo-LeiroMG, Stypmann J, Schulz U, et al. 2015. Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients. BMC Cardiovasc. Disord. 15:120
12. Cardoso F, van't Veer LJ, Bogaerts J, et al. 2016. 70-Gene signature as an aid to treatment decisions in early-stage breast cancer. N. Engl. J. Med. 375:717-29
13. McHugh L, Seldon TA, Brandon RA, et al. 2015. Amolecular host response assay to discriminate between sepsis and infection-negative systemic inflammation in critically ill patients: discovery and validation in independent cohorts. PLOS Med. 12:e1001916
14. Zimmerman JJ, Sullivan E, Yager TD, et al. 2017. Diagnostic accuracy of a host gene expression signature that discriminates clinical severe sepsis syndrome and infection-negative systemic inflammation among critically ill children. Crit. Care Med. 45:e418-e25
15. Gilad S, Meiri E, Yogev Y, et al. 2008. Serum microRNAs are promising novel biomarkers. PLOS ONE 3:e3148
16. Chaussabel D, Pascual V, Banchereau J. 2010. Assessing the human immune system through blood transcriptomics. BMC Biol. 8:84
17. van Houten CB, de Groot JAH, Klein A, et al. 2017. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect. Dis. 17:431-40
18. Chung HJ, Castro CM, Im H, et al. 2013. A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. Nat. Nanotechnol. 8:369-75
19. Yang WE,Woods CW,Tsalik EL. 2015. Host-based diagnostics for detection and prognosis of infectious diseases. In Methods in Microbiology, ed. A Sails, Y-W Tang, pp. 465-500. Amsterdam, Neth.: Elsevier
20. World Health Organization. 2016. Global Health Estimates 2015: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2015. Geneva:World Health Organ.
21. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. 2014. Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J. Antimicrob. Chemother. 69:234-40
22. Lee GC, Reveles KR, Attridge RT, et al. 2014. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC Med. 12:96
23. Ramilo O, Allman W, ChungW, et al. 2007. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109:2066-77
24. Hu X, Yu J, Crosby SD, Storch GA. 2013. Gene expression profiles in febrile children with defined viral and bacterial infection. PNAS 110:12792-97
25. Tsalik EL, Henao R, Nichols M, et al. 2016. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci. Transl. Med. 8:322ra11
26. Mejias A, Dimo B, Suarez NM, et al. 2013. Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLOS Med. 10:e1001549
27. Heinonen S, Jartti T, Garcia C, et al. 2016. Rhinovirus detection in symptomatic and asymptomatic children: value of host transcriptome analysis. Am. J. Respir. Crit. Care Med. 193:772-82
28. McClain MT, Nicholson BP, Park LP, et al. 2016. A genomic signature of influenza infection shows potential for presymptomatic detection, guiding early therapy, and monitoring clinical responses. Open Forum Infect. Dis. 3(1):ofw007. doi: 10.1093/ofid/ofw007
29. Suarez NM, Bunsow E, Falsey AR, et al. 2015. Superiority of transcriptional profiling over procalcitonin for distinguishing bacterial from viral lower respiratory tract infections in hospitalized adults. J. Infect. Dis. 212:213-22
30. Meaza A, Kebede A, Yaregal Z, et al. 2017. Evaluation of genotypeMTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect. Dis. 17:280
31. Berry MP, Graham CM, McNab FW, et al. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-77
32. Koth LL, Solberg OD, Peng JC, et al. 2011. Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am. J. Respir. Crit. Care Med. 184:1153-63
33. Koh GC, Schreiber MF, Bautista R, et al. 2013. Host responses to melioidosis and tuberculosis are both dominated by interferon-mediated signaling. PLOS ONE 8:e54961
34. Bloom CI, Graham CM, Berry MP, et al. 2013. Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers. PLOS ONE 8:e70630
35. Cliff JM, Lee JS, Constantinou N, et al. 2013. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207:18-29
36. Afshari A, Schrenzel J, Ieven M, Harbarth S. 2012. Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection-A new frontier? Crit. Care 16:222
37. Tenover FC. 2007. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin. Infect. Dis. 44:418-23
38. Caliendo AM, Gilbert DN, Ginocchio CC, et al. 2013. Better tests, better care: improved diagnostics for infectious diseases. Clin. Infect. Dis. 57(Suppl. 3):S139-70
39. Caliendo AM. 2015. Editorial commentary: rapid blood culture identification: the value of a randomized trial. Clin. Infect. Dis. 61:1081-83
40. Caliendo AM, Hanson KE. 2016. Point-counterpoint: the FDA has a role in regulation of laboratorydeveloped tests. J. Clin. Microbiol. 54:829-33
41. Ecker DJ, Sampath R, Li H, et al. 2010. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev. Mol. Diagn. 10:399-415
42. Warhurst G, Dunn G, Chadwick P, et al. 2015. Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review. Health Technol. Assess. 19(35):1-142
43. Evans SR, Hujer AM, Jiang H, et al. 2016. Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II. Clin. Infect. Dis. 62:181-89
44. Viau R, Frank KM, Jacobs MR, et al. 2016. Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin. Microbiol. Rev. 29:1-27
45. Yamamoto N, Hamaguchi S, Akeda Y, et al. 2015. Clinical specimen-direct LAMP: a useful tool for the surveillance of blaOXA-23-positive carbapenem-resistant Acinetobacter baumannii. PLOS ONE 10:e0133204
46. Bachmann LH, Johnson RE, Cheng H, et al. 2009. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J. Clin. Microbiol. 47:902-7
47. Huang S, Do J, Mahalanabis M, et al. 2013. Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis. PLOS ONE 8:e60059
48. Endimiani A, Hujer AM, Hujer KM, et al. 2010. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates. J. Clin. Microbiol. 48:2618-22
49. Fishbain JT, Sinyavskiy O, Riederer K, et al. 2012. Detection of extended-spectrum beta-lactamase and Klebsiella pneumoniae carbapenemase genes directly from blood cultures by use of a nucleic acid microarray. J. Clin. Microbiol. 50:2901-4
50. Lupo A, Papp-WallaceKM,Sendi P, et al. 2013. Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 77:179-94
51. Wright MS, Stockwell TB, Beck E, et al. 2015. SISPA-Seq for rapid whole genome surveys of bacterial isolates. Infect. Genet. Evol. 32:191-98
52. Buchan BW, Ledeboer NA. 2014. Emerging technologies for the clinical microbiology laboratory. Clin. Microbiol. Rev. 27:783-822
53. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. 2015. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin. Infect. Dis. 60:892-99
54. Farrell JJ, Sampath R, Ecker DJ, Bonomo RA. 2013. "Salvagemicrobiology": detection of bacteria directly from clinical specimens following initiation of antimicrobial treatment. PLOS ONE 8:e66349
55. Vincent JL, Brealey D, LibertN, et al. 2015. Rapid diagnosis of infection in the critically ill, a multicenter study of molecular detection in bloodstream infections, pneumonia, and sterile site infections. Crit. Care Med. 43:2283-91
56. Endimiani A, Hujer KM, Hujer AM, et al. 2011. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia? Clin. Infect. Dis. 52(Suppl. 4):S373-83
57. Banerjee R, Teng CB, Cunningham SA, et al. 2015. Randomized trial of rapidmultiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin. Infect. Dis. 61(7):1071-80